Pricing Log in Create free account

Cullinan Therapeutics, Inc. (CGEM) vs Nuvectis Pharma, Inc. (NVCT)

Cullinan Therapeutics, Inc. and Nuvectis Pharma, Inc. are both Biotechnology companies. Cullinan Therapeutics, Inc. and Nuvectis Pharma, Inc. are of similar size ($730.4M and $722.2M). Across the 8 metrics below, Nuvectis Pharma, Inc. leads on 5 and Cullinan Therapeutics, Inc. on 3.

Valuation

Metric CGEM NVCT Biotechnology median
P/E n/m n/m 11.58
P/S n/m n/m 9.61
P/B 2.16 4.90 2.26
Price to free cash flow n/m n/m 26.41
EV/EBITDA n/m n/m 0.72
EV/Sales n/m n/m 9.43
Earnings yield (27.39%) (8.97%) (32.28%)
Free cash flow yield (22.88%) (6.49%) (22.27%)

Profitability

Metric CGEM NVCT Biotechnology median
Gross margin — — 68.81%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (50.30%) (66.98%) (50.30%)
Return on assets (46.30%) (57.20%) (45.47%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CGEM NVCT Biotechnology median
Revenue growth (TTM) — — 6.78%
EPS growth (last fiscal year) (20.86%) (18.92%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CGEM NVCT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 8.42 9.92 4.74
Net debt to EBITDA 1.57 1.15 1.01

Dividend

Metric CGEM NVCT Biotechnology median
Dividend yield — — 0.39%
Payout ratio — — —

Size

Metric CGEM NVCT Biotechnology median
Market cap 730.42m 722.17m 168.63m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack